US hepatitis C patients travel to India for cheaper Sovaldi versions10 min read . Updated: 02 Jun 2015, 08:43 PM IST
Patients in the US and Europe have struggled to get access to the drug after insurers and governments limited its use to the sickest patients to control costs
New York/Mumbai: This is how far one Express Scripts Holding Co. executive was willing to go to secure inexpensive versions of Gilead Sciences Inc.’s hepatitis C drug Sovaldi, unavailable to US consumers under federal drug import and patent laws.
Select your Category